share_log
Moomoo 24/7 ·  Apr 24 03:00
CSL Vifor and Travere Therapeutics Announce European Commission Approves Filspari® (Sparsentan) for the Treatment of Iga Nephropathy
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment